» Articles » PMID: 30539418

ATP Synthase Subunit Beta Immunostaining is Reduced in the Sclerotic Hippocampus of Epilepsy Patients

Abstract

Epilepsy is a common disease presenting with recurrent seizures. Hippocampal sclerosis (HS) is the commonest histopathological alteration in patients with temporal lobe epilepsy (TLE) undergoing surgery. HS physiopathogenesis is debatable. We have recently studied, by using mass spectrometry-based proteomics, an experimental model of TLE induced by electrical stimulation. Specifically, protein expressions of both the beta subunit of mitochondrial ATP synthase (ATP5B) and of membrane ATPases were found to be reduced. Here, we investigated tissue distribution of ATP5B and sodium/potassium-transporting ATPase subunit alpha-3 (NKAα3), a protein associated with neuromuscular excitability disorders, in human hippocampi resected "en bloc" for HS treatment (n = 15). We used immunohistochemistry and the stained area was digitally evaluated (increase in binary contrast of microscopic fields) in the hippocampal sectors (CA1-CA4) and dentate gyrus. All HS samples were classified as Type 1, according to the International League Against Epilepsy (ILAE) 2013 Classification (predominant cell loss in CA1 and CA4). ATP5B was significantly decreased in all sectors and dentate gyrus of HS patients compared with individuals submitted to necropsy and without history of neurological alterations (n = 10). NKAα3 expression showed no difference. Moreover, we identified a negative correlation between frequency of pre-operative seizures and number of neurons in CA1. In conclusion, our data showed similarity between changes in protein expression in a model of TLE and individuals with HS. ATP5B reduction would be at least in part due to neuronal loss. Future investigations on ATP5B activity could provide insights into the process of such cell loss.

Citing Articles

Identifying cellular markers of focal cortical dysplasia type II with cell-type deconvolution and single-cell signatures.

Galvao I, Kandratavicius L, Messias L, Athie M, Assis-Mendonca G, Alvim M Sci Rep. 2023; 13(1):13321.

PMID: 37587190 PMC: 10432381. DOI: 10.1038/s41598-023-40240-3.


Epileptiform Discharges Reduce Neuronal ATP Production by Inhibiting F0F1-ATP Synthase Activity via A Zinc-α2-Glycoprotein-Dependent Mechanism.

Liang Y, Zhao L, Dai C, Liu G, Zhong Y, Liu H Mol Neurobiol. 2023; 60(11):6627-6641.

PMID: 37468739 DOI: 10.1007/s12035-023-03508-3.


Benchmarking the proteomic profile of animal models of mesial temporal epilepsy.

Canto A, Godoi A, Matos A, Geraldis J, Rogerio F, Alvim M Ann Clin Transl Neurol. 2022; 9(4):454-467.

PMID: 35238489 PMC: 8994989. DOI: 10.1002/acn3.51533.


Histopathological Correlations of Qualitative and Quantitative Temporopolar MRI Analyses in Patients With Hippocampal Sclerosis.

Zaidan B, Cardoso I, de Campos B, da Silva L, Coelho V, Silveira K Front Neurol. 2022; 12:801195.

PMID: 35002940 PMC: 8739995. DOI: 10.3389/fneur.2021.801195.


Neuroproteomics in Epilepsy: What Do We Know so Far?.

do Canto A, Donatti A, Geraldis J, Godoi A, da Rosa D, Lopes-Cendes I Front Mol Neurosci. 2021; 13:604158.

PMID: 33488359 PMC: 7817846. DOI: 10.3389/fnmol.2020.604158.


References
1.
Noh H, Lee H, Kim D, Kang S, Cho G, Rho J . A cDNA microarray analysis of gene expression profiles in rat hippocampus following a ketogenic diet. Brain Res Mol Brain Res. 2004; 129(1-2):80-7. DOI: 10.1016/j.molbrainres.2004.06.020. View

2.
Danis O, Demir S, Gunel A, Aker R, Gulcebi M, Onat F . Changes in intracellular protein expression in cortex, thalamus and hippocampus in a genetic rat model of absence epilepsy. Brain Res Bull. 2011; 84(6):381-8. DOI: 10.1016/j.brainresbull.2011.02.002. View

3.
Norwood B, Bumanglag A, Osculati F, Sbarbati A, Marzola P, Nicolato E . Classic hippocampal sclerosis and hippocampal-onset epilepsy produced by a single "cryptic" episode of focal hippocampal excitation in awake rats. J Comp Neurol. 2010; 518(16):3381-407. PMC: 2894278. DOI: 10.1002/cne.22406. View

4.
Engel Jr J . Introduction to temporal lobe epilepsy. Epilepsy Res. 1996; 26(1):141-50. DOI: 10.1016/s0920-1211(96)00043-5. View

5.
Hatanpaa K, Raisanen J, Herndon E, Burns D, Foong C, Habib A . Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal subfields. J Neuropathol Exp Neurol. 2014; 73(2):136-42. PMC: 4076969. DOI: 10.1097/OPX.0000000000000170. View